Company: Aseptika Ltd Competition Entered/ Phase: Improving the Health of People with Long-Term Conditions Innovation: Home use sputum test for the prediction of exacerbation of lung infections Total award: £1,242,500 awarded across Phase 1, Phase 2 & Phase 3 development stages Savings to the NHS: Estimated to be in excess of £50 million per annum Product availability: Q4 2016 Overview Aseptika is a healthcare company who with t

Join for free to read